Epitope analysis of GAD65Ab using fusion proteins and rFab

被引:13
作者
Binder, KA
Banga, JP
Madec, AM
Ortqvist, E
Luo, D
Hampe, CS
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] GKT Sch Med, Div Med, London, England
[3] Univ Lyon 1, Laennec Fac Med, INSERM, F-69622 Villeurbanne, France
[4] Karolinska Inst, Dept Woman & Child Hlth, S-10401 Stockholm, Sweden
关键词
type; 1; diabetes; fusion proteins; autoantibodies; epitopes; rFab; RIA;
D O I
10.1016/j.jim.2004.09.015
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The identification of disease-specific autoantibodies to the 65-kDa isoform of glutamate decarboxylase (GAD65Ab) epitopes in type 1 diabetes has been hampered by their conformational nature. Here, we compared two methods of GAD65Ab epitope analysis: GAD65/67 fusion proteins and competition assays using GAD65-specific recombinant fraction antigen binding (rFab). Sera from newly diagnosed type 1 diabetes patients (n=61) were studied using both approaches. Competition of GAD65 binding by an rFab to a specific epitope did not correlate with binding to the fusion protein that represented this epitope. Conversely, samples that bound to specific fusion proteins were not necessarily competed with rFab specific to determinants in the same region. We conclude that epitopes of different characteristics are detected by fusion proteins and by competition with rFab. Fusion proteins allow the definition of large epitope regions; however, some conformational GAD65Ab epitopes, especially those residing in the middle region, are destroyed or distorted in the fusion proteins. Competition studies using rFab allow the identification of conformational epitopes. However, monoclonal rFab may only reflect a limited proportion of the epitopes recognized by polyclonal sera. A combined analysis using both approaches may therefore be necessary to gain best understanding of autoantibody characteristics and affinity maturation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 26 条
[1]
ISLET CELL CYTOPLASMIC AUTOANTIBODY REACTIVITY TO GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
KAUFMAN, DL ;
NEWMAN, D ;
TOBIN, AJ ;
MACLAREN, NK .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :350-356
[2]
IDENTIFICATION OF THE 64K AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES AS THE GABA-SYNTHESIZING ENZYME GLUTAMIC-ACID DECARBOXYLASE [J].
BAEKKESKOV, S ;
AANSTOOT, HJ ;
CHRISTGAU, S ;
REETZ, A ;
SOLIMENA, M ;
CASCALHO, M ;
FOLLI, F ;
RICHTEROLESEN, H ;
CAMILLI, PD .
NATURE, 1990, 347 (6289) :151-156
[3]
GAD AUTOANTIBODIES IN IDDM, STIFF-MAN SYNDROME, AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE-I RECOGNIZE DIFFERENT EPITOPES [J].
BJORK, E ;
VELLOSO, LA ;
KAMPE, O ;
KARLSSON, FA .
DIABETES, 1994, 43 (01) :161-165
[4]
Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes [J].
Bonifacio, E ;
Lampasona, V ;
Bernasconi, L ;
Ziegler, AG .
DIABETES, 2000, 49 (02) :202-208
[5]
An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease [J].
Chattopadhyay, S ;
Ito, M ;
Cooper, JD ;
Brooks, AI ;
Curran, TM ;
Powers, JM ;
Pearce, DA .
HUMAN MOLECULAR GENETICS, 2002, 11 (12) :1421-1431
[6]
2 DISTINCT GLUTAMIC-ACID DECARBOXYLASE AUTOANTIBODY SPECIFICITIES IN IDDM TARGET DIFFERENT EPITOPES [J].
DAW, K ;
POWERS, AC .
DIABETES, 1995, 44 (02) :216-220
[7]
Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome [J].
Dinkel, K ;
Meinck, HM ;
Jury, KM ;
Karges, W ;
Richter, W .
ANNALS OF NEUROLOGY, 1998, 44 (02) :194-201
[8]
RADIOIMMUNOASSAYS FOR GLUTAMIC-ACID DECARBOXYLASE (GAD65) AND GAD65 AUTOANTIBODIES USING S-35 OR H-3 RECOMBINANT HUMAN LIGANDS [J].
FALORNI, A ;
ORTQVIST, E ;
PERSSON, B ;
LERNMARK, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 186 (01) :89-99
[9]
Falorni A, 1996, DIABETOLOGIA, V39, P1091
[10]
Species-specific autoantibodies in type 1 diabetes [J].
Hampe, CS ;
Örtqvist, E ;
Rolandsson, O ;
Landin-Olsson, M ;
Törn, C ;
Ågren, Å ;
Persson, B ;
Schranz, DB ;
Lernmark, Å .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :643-648